A few studies verified the potent antitumor activity of FLT3 ligand (FLT3L) in the murine BC model, which can open up new ideas for the development of tumor vaccines (Chen et al., 1997; Braun et al., 1999). This evidence concerns the gene FLT3LG and breast cancer.